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Tyrosine phosphorylation-dependent cell signaling represents a unique feature of multicellular organ-
isms, and is important in regulation of cell differentiation and specialized cell functions. Multicellular
organisms also contain a diverse family of NADPH oxidases (NOXs) that have been closely linked with
tyrosine kinase-based cell signaling and regulate tyrosine phosphorylation via reversible oxidation of
cysteine residues that are highly conserved within many proteins involved in this signaling pathway. An
example of redox-regulated tyrosine kinase signaling involves the epidermal growth factor receptor
(EGFR), a widely studied receptor system with diverse functions in normal cell biology as well as
pathologies associated with oxidative stress such as cancer. The purpose of this Graphical Redox Review
is to highlight recently emerged concepts with respect to NOX-dependent regulation of this important
signaling pathway.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
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The epidermal growth factor receptor (EGFR) is a member of
the extensively studied ErbB receptor tyrosine kinase family that
plays important roles in cell growth, development, differentiation,
cytoskeletal organization, and cell migration. The EGFR and other
ErbB members are activated by a family of ligands which promote
receptor homo- or heterodimerization resulting in autopho-
sphorylation of intracellular tyrosine residues, thereby recruiting
various adapter molecules and activating an array of downstream
signaling cascades [1]. In addition to this canonical activationB.V. This is an open access article u
d Laboratory Medicine, Uni-
eaumont Avenue, Burlington,
van der Vliet).mechanism, EGFR is also frequently activated in a cross-talk me-
chanism by initial stimulation of G-protein coupled receptors
(GPCRs), a large receptor family for diverse stimuli including
proteins, peptides, lipids, amino acids, biogenic amines, and ions.
Such EGFR transactivation occurs by two interrelated mechanisms,
the ﬁrst involving a “triple-membrane-passing-signal” in which
GPCR activation leads to activation of membrane-bound matrix
metalloproteases (MMPs) such as the ADAM (a disintegrin and
metalloprotease) family, which subsequently promotes shedding
of membrane-anchored EGFR ligands, allowing them to bind to
ErbB receptors [2]. In addition, GPCR-dependent EGFR activation
also involves ligand-independent mechanisms that result in direct
EGFR phosphorylation and activation, which is mediated by in-
termediate activation of protein kinases that include the non-re-
ceptor Src family kinases (SFK) or protein tyrosine kinase 2 (Pyk2)
(Fig. 1).nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Direct and indirect mechanisms of EGFR activation. Activation of EGFR by cognate ligands results in homo- or heterodimerization and autophosphorylation of
intracellular tyrosine residues (e.g., Y1068) to initiate cellular signaling. EGFR is commonly activated indirectly by activation of GPCR (transactivation), which involves
intermediate activation of protein kinases such as SFK, resulting in MMP/ADAM-dependent EGFR ligand shedding as well as direct phosphorylation of EGFR (Y845) to
promote EGFR kinase activation.
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Fig. 2. Interrelationships between NOX/DUOX enzymes and protein tyrosine
phosphorylation. Regulated activation of NOX/DUOX controls tyrosine phosphor-
ylation by reversible oxidative modiﬁcation of conserved cysteine residues with
protein tyrosine phosphatases (resulting in inactivation) or in protein tyrosine ki-
nases such as Src family kinases (SFK) or EGFR (which often enhances kinase
activity).
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Tyrosine kinase-based signaling, including EGFR, is well-known
to be subject to regulation by redox-dependent mechanisms at
various levels [3] (Fig. 2). The coincidence of tyrosineFig. 3. Diverse modes of NOX dependent regulation of EGFR activation. (A) Ligand-indu
PTP1B through intermediate NOX activation (eg. NOX2 or NOX4), resulting in its inac
activation. (B) Ligand-induced EGFR activation results in NOX2-dependent oxidation of
with enhanced kinase activity. (C) EGFR transactivation by GPCR stimulation (e.g., P2Y2R)
promotes Src activation and subsequent MMP/ADAM-dependent EGFR ligand sheddingphosphorylation as an important signaling mechanism in multi-
cellular organisms with increased diversity in NADPH oxidase
(NOX) isoforms, the major source of regulated ROS production, in
these more complex organisms suggests an intricate relationship
in the evolution of these systems [4,5]. Pioneering studies by Rhee
and co-workers illustrated that activation of EGFR is associated
with ROS production, which transiently inactivates protein tyr-
osine phosphatases (PTPs) to enhance or prolong EGFR activation
[6]. Such redox-mediated PTP inactivation is due to oxidation of a
susceptible conserved catalytic cysteine residue that is essential
for phosphotyrosine hydrolysis [7]. More recent studies high-
lighted the importance of regulated ROS production by NOX family
NADPH oxidases in site-speciﬁc PTP inactivation in spatially con-
ﬁned areas, e.g. by NOX4 in the ER [8] or NOX2 at sites of focal
adhesion [9]. Indeed, such NOX-dependent PTP inactivation is now
well appreciated in promoting EGFR-dependent signaling (Fig. 3A).
In addition to the well-documented negative regulation of PTPs
by oxidative mechanisms, evidence is emerging that protein tyr-
osine kinases are also subject to more direct redox regulation [10].
This is best studied in the SFK family, which contain a number of
conserved cysteines, whose oxidation either promotes or restricts
kinase activity. The EGFR, like several other protein kinases, con-
tains a non-catalytic nucleophilic cysteine (Cys797 within EGFR),
localized in the hinge region of its catalytic domain, which isced EGFR activation is associated with transient cysteine oxidation (-S-Ox) within
tivation and relieving its inhibitory action of EGFR tyrosine phosphorylation and
a conserved cysteine within the EGFR kinase domain (Cys797), which is associated
involves NOX activation (DUOX1 or NOX1) and cysteine oxidation within Src, which
and as well as direct EGFR phosphorylation.
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Sulfenic Acid 
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Fig. 4. Proposed role for reversible oxidation of C797 in EGFR kinase activation.
Crystal structure of EGFR kinase domain (PDB: 3GT8) showing C797 in the hinge
region within the ATP binding pocket [revealed using its analog adenosine 5′-(β,γ-
imido)triphosphate (AMP-PNP)]. Inset: Cyclic model illustrating H2O2-dependent
thiol oxidation to sulfenic acid followed by mixed disulﬁde formation with GSH (S-
glutathionylation) and reduction to original thiol by thiol reductases (e.g. glutar-
edoxin). Whereas sulfenylation of C797 may promote ATP hydrolysis, S-glutathio-
nylation is likely to prevent ATP binding and inhibits kinase activity.
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found to be oxidized to a sulfenic acid (–SOH) in response to li-
gand-induced EGFR activation, by recruitment and activation of
NOX2 through as yet unidentiﬁed mechanisms, and was associated
with increase tyrosine kinase activity [12] (Fig. 3B). Analogous
sulfenylation of comparable Cys residues in other tyrosine kinases
may similarly regulate kinase activity.
Recent studies by our group towards the mechanisms of EGFR
activation in the airway epithelium in the context of epithelial
injury or environmental allergen challenge has revealed the im-
portance of GPCRs such as purinergic P2Y2 receptors, protease-
activated receptors (PAR2), or histaminergic receptors (H1R), and
the prominent epithelial NADPH oxidase isoform DUOX1, which
critically mediates EGFR transactivation. In case of
P2Y2R-mediated EGFR transactivation, this was associated with
recruitment of Src and DUOX1 to the P2Y2R signaling complex, and
cysteine oxidation within Src [13], suggesting direct targeting of
Src by DUOX1-derived ROS to promote Src activation and EGFR
transactivation (Fig. 3C). As another example, thrombin-mediated
EGFR transactivation in smooth muscle cells involves similar re-
dox-dependent Src activation by NOX1 [14].
Collectively, various modes of NOX-mediated oxidative EGFR
regulation have been identiﬁed, which may not act independently
but might act in concert to control this important signaling
pathway at various distinct levels. NOX-dependent cysteine oxi-
dation of PTP1B or EGFR itself may not be essential for EGFR ac-
tivation, but rather serve to control the strength and duration of
EGFR signaling, which critically determines biological outcomes. In
contrast, the DUOX1-dependent oxidative activation of Src and
EGFR ligand shedding is critical in initiating EGFR signaling in this
transactivation pathway. More recent studies in our lab indicated
that DUOX1-dependent EGFR activation involves cysteine oxida-
tion within Src as well as EGFR and PTP1B [15,16], where the latter
may involve more indirect mechanisms by other NOX isoforms or
other ROS sources activated in response to initial EGFR activation
to regulate the extent and duration of EGFR activation.3. Proposed redox-dependent mechanism of EGFR tyrosine
kinase regulation
The precise molecular mechanisms by which these distinct
oxidative events control EGFR-dependent signaling is not always
clear. While it is well-appreciated that oxidation of the catalyticcysteine within PTPs results in impaired phosphatase activity, ir-
respective of the nature of the oxidative modiﬁcation (S-ni-
trosylation, S-glutathionylation, sulfenyl amide formation), it is
less obvious how oxidative modiﬁcations of non-catalytic cy-
steines in tyrosine kinases affect enzyme activity. Indeed, oxidative
modiﬁcation of one or more conserved cysteines in SFKs have
been linked with either enhanced or reduced kinase activity, but
the precise molecular mechanisms is still unclear [10,17]. In-
triguingly, oxidation of Cys797 in the ATP-binding pocket of EGFR
to a sulfenic acid was linked to enhanced kinase activity, poten-
tially due to altered electrostatic or hydrogen bonding interaction
with its substrate [18]. In contrast, other oxidative modiﬁcations of
this Cys residue, to either S-glutathionylated adducts or to sulfonic
acids, do not enhance tyrosine kinase activity [11] and might in
fact be inhibitory due to steric constraints imposed by more bulky
modiﬁcations of this Cys residue. Indeed, Cys797 is also the target
for recently developed covalent EGFR inhibitors that have been
used to treat lung cancers with activating EGFR mutations [19].
Based on these considerations, we propose that reversible oxida-
tion of Cys797, which likely involves initial sulfenic acid formation
that is subsequently resolved by S-glutathionylation and reduc-
tion, represents another level of dynamic redox-dependent EGFR
regulation, complementing its regulation by tyrosine phosphor-
ylation/dephosphorylation (Fig. 4).4. Conclusion
In conclusion, current experimental evidence indicates a tight
interrelationship between NOX-dependent ROS production and
redox-mediated regulation of tyrosine kinases such as EGFR. The
highly diverse nature of EGFR signaling in various cellular contexts
is therefore not only explained by the diversity in EGFR ligands
and/or variable EGFR homo- or heterodimerization, but also by
variable expression and activation of diverse NOX enzymes which
can control EGFR activation at various levels and thereby regulate
either initiation of EGFR transactivation or the extent of EGFR
activation and its diverse downstream signaling pathways. Hence,
abnormalities in EGFR activation in the context of chronic diseases
such as cancer or asthma may not simply be due to altered ex-
pression of EGFR or its ligands, but also be related to altered ex-
pression or activation of NOX enzymes that regulate this signaling
pathway.Acknowledgments
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